Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Essen Biotech
Royal Marsden NHS Foundation Trust
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
University of Southern California
Maria Sklodowska-Curie National Research Institute of Oncology
Gustave Roussy, Cancer Campus, Grand Paris
Transgene
Seattle Children's Hospital
Tango Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
University of California, Irvine
Valo Therapeutics Oy
Epkin
Dana-Farber Cancer Institute
Yonsei University
University of Iowa
Memorial Sloan Kettering Cancer Center